These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20552891)

  • 1. [Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
    Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
    Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
    Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
    PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer.
    He Q; Chen HY; Bai EQ; Luo YX; Fu RJ; He YS; Jiang J; Wang HQ
    Cancer Genet Cytogenet; 2010 Oct; 202(1):1-10. PubMed ID: 20804913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.
    Wasserkort R; Kalmar A; Valcz G; Spisak S; Krispin M; Toth K; Tulassay Z; Sledziewski AZ; Molnar B
    BMC Cancer; 2013 Aug; 13():398. PubMed ID: 23988185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of methylated free circulating DNA in colorectal cancer.
    Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
    Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
    Herbst A; Wallner M; Rahmig K; Stieber P; Crispin A; Lamerz R; Kolligs FT
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):565-9. PubMed ID: 19282772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
    Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
    PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer.
    Philipp AB; Nagel D; Stieber P; Lamerz R; Thalhammer I; Herbst A; Kolligs FT
    BMC Cancer; 2014 Apr; 14():245. PubMed ID: 24708595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
    Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
    Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
    Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
    Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of expression level and methylation profile of
    Mohammadi Z; Azad M; Foroughi F; Khojastehpour S; Gheibi N; Samiee-Rad F; Maali A; Ahmadi MH
    J Cancer Res Ther; 2021; 17(6):1328-1334. PubMed ID: 34916361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of
    Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
    Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis.
    Hibi K; Kodera Y; Ito K; Akiyama S; Nakao A
    Dis Colon Rectum; 2005 Jun; 48(6):1282-6. PubMed ID: 15793636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
    Sun G; Meng J; Duan H; Zhang D; Tang Y
    Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly methylated genes in colorectal neoplasia: implications for screening.
    Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas.
    Ebert MP; Model F; Mooney S; Hale K; Lograsso J; Tonnes-Priddy L; Hoffmann J; Csepregi A; Röcken C; Molnar B; Schulz HU; Malfertheiner P; Lofton-Day C
    Gastroenterology; 2006 Nov; 131(5):1418-30. PubMed ID: 17101318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.